Is Miconazole + Mometasone registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 7 valid registrations of Miconazole + Mometasone, including Avocom-M Cream (2,0.1 %,%, Cream, SAR 37.25); ELICA-M CREAM (2,0.1 %,%, Cream, SAR 25.55); LOCASONE M cream (2,0.1 %,%, Cream, SAR 21.00).

Active substances

Miconazole + Mometasone

SFDA 7

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Avocom-M Cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 37.25	Generic · Prescription	Middle East Pharmaceutical Industries Co Ltd Avalon Pharma	Valid
Avocom-M Cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 23.00	Generic · Prescription	Middle East Pharmaceutical Industries Co Ltd Avalon Pharma	Valid
ELICA-M CREAM	2,0.1 %,%	Cream · Topical	1 Tube	SAR 25.55	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Valid
LOCASONE M cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 21.00	Generic · Prescription	DEEF PHARMACEUTICAL INDUSTRIES	Valid
LOCASONE M cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 35.00	Generic · Prescription	DEEF PHARMACEUTICAL INDUSTRIES	Valid
LOCASONE M cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 70.00	Generic · Prescription	DEEF PHARMACEUTICAL INDUSTRIES	Valid
LOCASONE M cream	2,0.1 %,%	Cream · Topical	1 Tube	SAR 10.35	Generic · Prescription	DEEF PHARMACEUTICAL INDUSTRIES	Valid

Indications — CHI Daman Drug Formulary

ECZEMA; FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF VULVA AND VAGINA & CANDIDIASIS OF OTHER UROGENITAL SITES

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.